MedPath

Data Driven Behavior Intervention and Medical Outcome Evaluation of Patients' Comprehensive Monitoring

Conditions
Metabolic Syndrome
Metabolic Disturbance
Obesity
Metabolic Complication
Infection
Diabetes
Registration Number
NCT04966754
Lead Sponsor
Peking Union Medical College Hospital
Brief Summary

During the study, the resuscitation room, general wards and ICU were installed fixed or mobile acquisition devices in the resuscitation room, the emergency department of Peking Union Medical College Hospital, and the collection platform was set up. Patients with acute diseases (infection, diabetes complications, etc.) caused by metabolic syndrome (obesity, diabetes, etc.) were selected after informed consent. All medical intervention behaviors, relevant medical records and medical outcome records within the collection scope of the device platform were collected prospectively . And regular follow-up, guidance of patients with metabolic syndrome control, while collecting all the lifestyle characteristics of patients, some patients with metabolic cabin research, and observe the relevant medical outcomes. After that, all the collected data were coded, and the influence of all lifestyle and medical behavior interventions on patients' medical outcomes was studied by artificial intelligence method.

Detailed Description

Not available

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
1000
Inclusion Criteria
  • Diabetes and / or obesity (BMI>=28).
  • Emergency room / emergency ward / EICU;
  • Be able to understand and agree the research protocol and sign the informed consent
Exclusion Criteria
  • Pregnant women / lactation period;
  • The estimated survival time was less than 1 year;
  • Long term follow-up is not guaranteed;
  • Failure to comply with the protocol or procedure;
  • The collection of medical behavior data can not complete the de privacy or label after de privacy;
  • Other researchers think that it is not suitable for inclusion

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Rate of metabolic complications6 weeks

Relapse of acute metabolic disease, stability of biochemical metabolic indexes (such as glycosylated hemoglobin, BMI)

Rate of mortality6 months

30-day and 90-day mortality. Death due to cardiovascualr complications

Complication control3 weeks

The occurrence of metabolic complications, infection and cardiovascular events

Secondary Outcome Measures
NameTimeMethod
Total cost of treatment3 weeks

Length of stay, length of stay in ICU, ventilator usage time

Quality of life6 months

Dynamic monitoring of quality of life through quality-of-life evaluation chart

Ā© Copyright 2025. All Rights Reserved by MedPath